首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1747754

心臟假體市場按產品類型、最終用戶和地區分類

Cardiac Prosthetic Devices Market, By Product Type, By End User, and by Region

出版日期: 2025年05月06日 | 出版商:

Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年心臟假體市場規模估計為 89.6 億美元，預計到 2032 年將達到 167 億美元，2025 年至 2032 年的複合年成長率為 9.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	89.6億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	9.30%	2032年價值預測	167億美元

心臟假體包括機械和組織人工心臟瓣膜、環狀成形術環、心律調節器和心臟去顫器導線、組織補片、輔助心臟假體等。這些產品用於替換受損或患病心臟的自體瓣膜。預計在預測期內，高血壓的上升將刺激全球心臟假體市場的擴張。研究的增加和產品的推出也有望推動市場擴張。

市場動態

主要市場參與企業正專注於採用各種成長策略，例如產品發布、夥伴關係等，以加強其產品系列和市場地理影響力，預計這將在預測期內推動全球心臟假體市場的成長。例如，2023 年 6 月 8 日，醫療設備製造商雅培發布了其經導管邊對邊修復 (TEER) 設備 MitraClip 和全球首款微創三尖瓣修復設備 TriClip 的結果數據。這些數據強化了該公司針對二尖瓣和三尖瓣逆流 (MR 和 TR) 的結構性心臟解決方案對廣大心臟瓣膜漏出病患小組的效果。

同樣，2022 年 10 月，醫療設備公司 Ceryx Medical 宣布與醫療設備公司 Osypka Medical 合作開發一種用於心臟衰竭和其他心臟疾病患者的心臟起搏裝置。

此外，醫療設備公司雅培於2022年2月宣布，作為AVEIR DR i2i關鍵臨床試驗的一部分，開始在病患中植入其雙腔無導線心律調節器系統。雅培在臨床實驗的AVAIR雙腔無導線心律調節器的植入代表無導線起搏技術的突破。

本研究的主要特點

本報告對全球心臟假體市場進行了詳細分析，並提供了預測期 2025-2032 的市場規模和年複合成長率(CAGR)，假設 2024 年為基準年。
它還揭示了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球心臟假體市場的主要企業已根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行了分析。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球心臟假體市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過用於分析全球心臟假體市場的各種策略矩陣更輕鬆地做出決策。

市場動態
- 驅動程式
- 限制因素
- 市場機會
影響分析
最新產品發布
流行病學
合併、收購和合作
監管情景
主要進展
PEST分析
夥伴關係場景
品牌與價格分析
經銷商狀況
所有類型心臟瓣膜和心律調節器的概述
波特分析
技術進步
主要進展
市場趨勢
心臟假體的成長與需求未來前景
按收益的頂級市場參與者

4. 全球心臟假體市場-COVID-19影響分析

經濟影響
COVID-19流行病學
對需求和供給的影響

5. 全球心臟假體市場（依產品類型），2020 年至 2032 年

心臟瓣膜
心律調節器

6. 全球心臟假體市場（依最終使用者分類），2020 年至 2032 年

醫院
專科診所
門診手術中心
其他（學術研究機構等）

7. 全球心臟假體市場（按地區分類），2020 年至 2032 年

北美洲
拉丁美洲
歐洲
亞太地區
中東
非洲

第8章競爭態勢

Abbott
Artivion, Inc.
Medtronic
Boston Scientific Corporation
Edwards Lifesciences Corporation.
Siemens Healthcare Private Limited
LivaNova PLC（Sorin Group）
Asahi Kasei Corporation.
OSYPKA MEDICAL
Lepu Medical
MicroPort Scientific Corporation.
Vitatron
Koninklijke Philips NV,
Progetti srl
Shree Pacetronix Ltd.

第9章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI3862

Cardiac Prosthetic Devices Market is estimated to be valued at USD 8.96 Bn in 2025 and is expected to reach USD 16.7 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 8.96 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.30%	2032 Value Projection:	USD 16.7 Bn

Cardiac prosthetic devices include mechanical and tissue prosthetic heart valves, annuloplasty rings, pacemaker and defibrillator leads, tissue patches, artificial hearts, and ventricular assist devices. These are used to replace the heart's native valves that have been harmed or become ill. Over the forecast period, rising levels of hypertension are anticipated to fuel market expansion for cardiac prosthetic devices worldwide. The market is also expected to rise as a result of increased research and product introductions.

Market Dynamics

The key market players are focused on adopting various growth strategies such as product launches, partnerships, and others to strengthen their product portfolio and geographical presence in the market, which in turn is expected to drive the growth of the global cardiac prosthetics devices market over the forecast period. For instance, on June 8, 2023, Abbott, a medical device company, announced result data for MitraClip, which is a transcatheter edge-to-edge repair (TEER) device, and TriClip, a first-of-its-kind minimally invasive tricuspid heart valve repair device. The data reinforce the capabilities of the company's structural heart solutions for both mitral and tricuspid regurgitation (MR and TR) across a broad range of patient groups battling leaky heart valves.

Similarly, in October 2022, Ceryx Medical, a medical device company, in partnership with Osypka Medical, a medical device company, announced the development of a heart-pacing device for patients with heart failure and other cardiac conditions

Furthermore, in February 2022, Abbott, a medical device company, announced the launch of patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i pivotal clinical study. The implant of Abbott's investigational Aveir dual-chamber leadless pacemaker represents technological leadless pacing technology.

Key features of the study

This report provides an in-depth analysis of the global cardiac prosthetics devices market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cardiac prosthetics devices market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott, Artivion, Inc., Medtronic, Boston Scientific Corporation, Edwards Lifesciences Corporation., Siemens Healthcare Private Limited, LivaNova PLC (sorin group), Asahi Kasei Corporation., OSYPKA MEDICAL, Lepu Medical, MicroPort Scientific Corporation., Vitatron, Koninklijke Philips N.V., Progetti srl and Shree Pacetronix Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global Cardiac Prosthetics Devices Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac prosthetics devices market.

Market Segmentation

Global Cardiac Prosthetic Devices Market, By Product Type:
- Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Stented tissue valve
- Stentless tissue valve
- Transcatheter Heart Valves
- Pacemaker
- Implantable pacemakers
- Single-Chamber Battery Pacemaker
- Dual-Chamber Battery Pacemaker
- Triple-Chamber Battery Pacemaker
- External Pacemaker
Global Cardiac Prosthetic Devices Market, By End user:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others (Academic & Research Institutes and Others)
Global Cardiac Prosthetic Devices Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Abbott.
- Artivion, Inc.
- Medtronic
- Boston Scientific Corporation
- Edwards Lifesciences Corporation.
- Siemens Healthcare Private Limited
- LivaNova PLC (Sorin Group)
- Asahi Kasei Corporation.
- OSYPKA MEDICAL
- Lepu Medical
- MicroPort Scientific Corporation.
- Vitatron
- Koninklijke Philips N.V.,
- Progetti srl
- Shree Pacetronix Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By End user
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
Partnership Scenario
Brand and Pricing Analysis
Distributors Landscape
Overview on all types of heart valve and pacemakers
Porters Analysis
Technological Advancements
Key Developments
Market Trend
Future Prospective on growth and demand of Cardiac Prosthetics Devices
Top Market Players by Revenue

4. Global Cardiac Prosthetic Devices Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Cardiac Prosthetic Devices Market, By Product Type, 2020 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Heart Valves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
  - Mechanical Heart Valves
  - Tissue Heart Valves
    - Stented tissue valve
    - Stentless tissue valve
  - Transcatheter Heart Valves
Pacemaker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
  - Implantable pacemakers
    - Single-Chamber Battery Pacemaker
    - Dual-Chamber Battery Pacemaker
    - Triple-Chamber Battery Pacemaker
  - External Pacemaker

6. Global Cardiac Prosthetic Devices Market, By End user, 2020 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Others (Academic & Research Institutes and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

7. Global Cardiac Prosthetic Devices Market, By Region, 2020 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2020 - 2032, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Artivion, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Edwards Lifesciences Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Siemens Healthcare Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
LivaNova PLC (Sorin Group)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Asahi Kasei Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
OSYPKA MEDICAL
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lepu Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
MicroPort Scientific Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Vitatron
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Koninklijke Philips N.V.,
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Progetti srl
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Shree Pacetronix Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies